Literature DB >> 17170125

TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation.

Cheng Qian1, Huazhang An, Yizhi Yu, Shuxun Liu, Xuetao Cao.   

Abstract

Dendritic cells (DCs) and chemokines are important mediators linking innate and adaptive immunity on activation by Toll-like receptor (TLR) agonists. We previously identified a kind of regulatory DC subset (diffDCs) that differentiated from mature DCs under splenic stroma and that inhibited T-cell proliferation. The responsiveness of such regulatory DCs to TLR agonists and their pattern of chemokine production remain to be determined. Here, we report that the regulatory DCs secrete a higher level of CXCR3 chemokine IFN-gamma-induced protein-10 (IP-10) than immature DCs (imDCs), and more IP-10 is produced after stimulation with TLR-2, -4, -3, and -9 ligands. Blockade of IFN-alpha/beta inhibits IP-10 production by TLR agonist-activated regulatory DCs. We show that the increased IRF-3 and IFN-beta-induced STAT1 activation are responsible for the autocrine IFN-beta-dependent preferential production of IP-10 by regulatory DCs. In addition, stimulation with recombinant mouse IFN-alpha/beta induces more IP-10 production in regulatory DCs than that in imDCs. Moreover, the regulatory DCs selectively recruit more Th1 cells through IP-10 and inhibit Th1 proliferation. Our results demonstrate a new manner for regulatory DCs to down-regulate T-cell response by preferential IP-10 production and inhibition of recruited Th1 cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170125     DOI: 10.1182/blood-2006-08-040337

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus.

Authors:  Yuan Fang; Thomas Rowe; Alberto J Leon; David Banner; Ali Danesh; Luoling Xu; Longsi Ran; Steven E Bosinger; Yi Guan; Honglin Chen; Cheryl C Cameron; Mark J Cameron; David J Kelvin
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Specific recruitment of γδ regulatory T cells in human breast cancer.

Authors:  Jian Ye; Chunling Ma; Fang Wang; Eddy C Hsueh; Karoly Toth; Yi Huang; Wei Mo; Shuai Liu; Bing Han; Mark A Varvares; Daniel F Hoft; Guangyong Peng
Journal:  Cancer Res       Date:  2013-08-19       Impact factor: 12.701

3.  Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK/β-catenin pathway.

Authors:  Cheng Qian; Li Qian; Yizhi Yu; Huazhang An; Zhenhong Guo; Yanmei Han; Yongjian Chen; Yi Bai; Qingqing Wang; Xuetao Cao
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

Review 4.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

Review 5.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

Review 6.  CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

Authors:  Ryuma Tokunaga; Wu Zhang; Madiha Naseem; Alberto Puccini; Martin D Berger; Shivani Soni; Michelle McSkane; Hideo Baba; Heinz-Josef Lenz
Journal:  Cancer Treat Rev       Date:  2017-11-26       Impact factor: 12.111

Review 7.  Natural and Induced Tolerogenic Dendritic Cells.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  J Immunol       Date:  2020-02-15       Impact factor: 5.422

Review 8.  Immunopathogenesis of Staphylococcus aureus pulmonary infection.

Authors:  Dane Parker; Alice Prince
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

9.  Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.

Authors:  M Anthony Moody; Sampa Santra; Nathan A Vandergrift; Laura L Sutherland; Thaddeus C Gurley; Mark S Drinker; Ashley A Allen; Shi-Mao Xia; R Ryan Meyerhoff; Robert Parks; Krissey E Lloyd; David Easterhoff; S Munir Alam; Hua-Xin Liao; Brandy M Ward; Guido Ferrari; David C Montefiori; Georgia D Tomaras; Robert A Seder; Norman L Letvin; Barton F Haynes
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

10.  Suppression of T-cell chemokines by Porphyromonas gingivalis.

Authors:  Catherine E Jauregui; Qian Wang; Christopher J Wright; Hiroki Takeuchi; Silvia M Uriarte; Richard J Lamont
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.